Amalgamated Bank’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Amalgamated Bank's SWTX Position: Q2 2025 in Review
Amalgamated Bank sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 2,433 shares — an estimated $107K sold.
Amalgamated Bank first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $454K in Q2 2021. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Amalgamated Bank reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Amalgamated Bank sold 2,433 SpringWorks Therapeutics shares in Q2 2025, an estimated $107K.
- Amalgamated Bank first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
- Amalgamated Bank's SpringWorks Therapeutics position peaked at $454K in Q2 2021.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.